Section Arrow
Quote
BGLC.NASDAQ
- Bionexus Gene Lab Corp
Quotes are at least 15-min delayed:2025/07/01 12:16 EDT
Last
 10.57
+7.5 (+244.30%)
Day High 
15.6 
Prev. Close
3.07 
1-M High
4.53 
Volume 
41.68M 
Bid
10.51
Ask
10.62
Day Low
8.83 
Open
10.145 
1-M Low
2.6 
Market Cap 
5.52M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.82 
20-SMA 2.99 
50-SMA 2.96 
52-W High 8.4 
52-W Low 2.0068 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.19/--
Enterprise Value
5.68M
Balance Sheet
Book Value Per Share
4.33
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.51M
Operating Revenue Per Share
5.77
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BGLCBionexus Gene Lab Corp10.57+7.5+244.30%-- 
ECVTEcovyst7.685-0.545-6.62%14.38PE
CCChemours Company (The)12.475+1.025+8.95%63.61PE
LYBLyondellBasell Industries NV61.39+3.53+6.10%20.02PE
GEVOGevo1.3397+0.0197+1.49%-- 
Quotes are at least 15-min delayed：2025/07/01 12:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asiaregion. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.